Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms.

Cimen Bozkus C, Roudko V, Finnigan JP, Mascarenhas J, Hoffman R, Iancu-Rubin C, Bhardwaj N.

Cancer Discov. 2019 Sep;9(9):1192-1207. doi: 10.1158/2159-8290.CD-18-1356. Epub 2019 Jul 2.

PMID:
31266769
2.

Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial.

Rubinsteyn A, Kodysh J, Hodes I, Mondet S, Aksoy BA, Finnigan JP, Bhardwaj N, Hammerbacher J.

Front Immunol. 2018 Jan 18;8:1807. doi: 10.3389/fimmu.2017.01807. eCollection 2017.

3.

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.

Finnigan JP Jr, Rubinsteyn A, Hammerbacher J, Bhardwaj N.

Oncology (Williston Park). 2015 Dec;29(12):970-2, 974-5. Review. No abstract available.

4.

TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer.

Levovitz C, Chen D, Ivansson E, Gyllensten U, Finnigan JP, Alshawish S, Zhang W, Schadt EE, Posner MR, Genden EM, Boffetta P, Sikora AG.

Cancer Res. 2014 Dec 1;74(23):6833-44. doi: 10.1158/0008-5472.CAN-14-0602-T. Epub 2014 Oct 1.

5.

Counseling the patient with potentially HPV-related newly diagnosed head and neck cancer.

Finnigan JP Jr, Sikora AG.

Curr Oncol Rep. 2014 Mar;16(3):375. doi: 10.1007/s11912-013-0375-8. Review.

6.

Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis.

French BA, Mazur W, Ali NM, Geske RS, Finnigan JP, Rodgers GP, Roberts R, Raizner AE.

Circulation. 1994 Nov;90(5):2402-13.

PMID:
7955199
7.

Computers and blood team up for better patient service.

Peterson EL, Finnigan JP.

Hosp Manage. 1968 Mar;105(3):60-2. No abstract available.

PMID:
5640201

Supplemental Content

Loading ...
Support Center